Drug intelligence / Profile preview

Osteobrix Tablets

Development stage
Unknown
Lead developer
Stevia Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Osteobriks Tablets (commonly marketed as Osteobrix) is a nutritional supplement developed by Stevia Pharmaceuticals, an Indian pharmaceutical company. The product is formulated to support bone health and address calcium deficiency. It typically contains a combination of calcium citrate and elemental magnesium. Calcium citrate is utilized for its high bioavailability in providing elemental calcium, which is a primary structural component of bone tissue and is necessary for various physiological processes including muscle contraction and nerve signaling. Magnesium is included to facilitate calcium absorption and serve as a cofactor for enzymes involved in bone formation and the regulation of calcium homeostasis. The product is approved and marketed in India for individuals requiring mineral supplementation to prevent or treat conditions like osteoporosis and hypocalcemia.

Brand names
Osteobrix TabletsOsteobriks TabletsOsteobrix Tab
Other names
calcium citrate + magnesium
02

Targets

CaSR (Extracellular calcium-sensing receptor)

Beyond the preview

Go deeper on Osteobrix Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osteobrix Tablets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call